FDA cotraataca/ 2011 = 35

Frente a cuestionamientos...



La "nueva realidad"


Click sobre imagen para ampliar

"FDA’s performance during the most recent fiscal year (October 1, 2010 – September 30, 2011) demonstrates that the FDA continues to lead the world in rapid, high-quality drug reviews.
FDA approved 35 innovative drugs in FY 2011, many of them groundbreaking. This is among the highest number of approvals in the past decade, surpassed only by 2009 (37).
But few years have seen as many important advances for patients."







Descargar